Outcomes associated with pharmacotherapy in overactive bladder

Overactive bladder is one of the most prevalent medical conditions in the USA. Prevalence rates of overactive bladder are higher in women and increase with advanced age. Although the disease is not associated with mortality, it has significant impact on health-related quality of life amongst patients. Pharmacologic, as well as behavioral treatment therapies, are available for overactive bladder treatment with pharmacologic agents being the mainstay therapy. The purpose of this review is to outline the recent developments in the treatment of overactive bladder. This is an extensive review that provides important information on the outcomes associated with different pharmacotherapeutic agents used in overactive bladder. It concludes with the authors opinions and suggestions for the future research in this area.